Dear Administrator Oz:
The undersigned member organizations of the Diabetes Advocacy Alliance (DAA) are pleased to submit comments to the Centers for Medicare & Medicaid Services (CMS) regarding the proposed rule: Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program (CY 2027 PFS).
The DAA is diverse in scope, with our members representing patients, healthcare providers, suppliers, and more all united to change the way diabetes is viewed and treated in America. Since 2010, the DAA has worked with legislators and policymakers to increase awareness of, and action on, the diabetes epidemic.
